The Economist @TheEconomist
Psychedelics are not the only new approach to clinical neuroscience. But their study in clinical settings should yield some helpful therapeutic advances and new insights into the way minds sit in brains https://t.co/3Aud3HzIXQ https://t.co/0htqWJNgTg — PolitiTweet.org